Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1393-1402

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autonomic dysfunction in cirrhosis and portal hypertension

By Dumcke Christine Winkler   Møller Søren  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 6, 2008-10 ,pp. : 437-447

Informa Healthcare

Access to resources Recommend Favorite

Sexual Function Assessment and the Role of Vasoactive Drugs in Female Sexual Dysfunction

By Rosen Raymond C.  

Archives of Sexual Behavior, Vol. 31, Iss. 5, 2002-10 ,pp. : 439-443

Springer Publishing Company

Access to resources Recommend Favorite

An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis

By Wechowski Jaroslaw   Connolly Mark   Woehl Anette   Tetlow Anthony   McEwan Phil   Burroughs Andrew   Currie Craig J.   Bhatt Aomesh  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1481-1491

Informa Healthcare

Access to resources Recommend Favorite

Q-T interval (QTC) in patients with cirrhosis: relation to vasoactive peptides and heart rate

By Henriksen J. H.   Gülberg V.   Fuglsang S.   Schifter S.   Bendtsen F.   Gerbes A. L.   Møller S.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 6, 2007-01 ,pp. : 643-653

Informa Healthcare

Access to resources Recommend Favorite